Skip to content
Mendelspod Podcast cover art

All episodes

Mendelspod Podcast, 582 episodes. Page 3 of 6.

#
Title
201

The Bioengineered Hangover Cure: Changing the Conversation around GMOs with Zack Abbott of ZBiotics

202

Lance Baldo of Freenome on their Approach to Early Cancer Detection

203

Mara Aspinall on COVID

204

Terry Lo of Vizgen on Spatial Genomics

205

Proteomics at Scale Empowers Genomics in New Ways: Dale Yuzuki, Olink

206

A New Tool in the Genomics Kit with Ivan Liachko of Phase Genomics

207

Paul Kruszka of GeneDx/Sema4 on Groundbreaking Newborn Sequencing Study

208

Is PGx Having a Moment? Kristine Ashcraft, Invitae

209

Christian Henry on Revio, Onso and the New Vision at PacBio

210

The Revolution in Single Molecule Sequencing Continues: Vijay Ramani, UCSF

211

Will Hwang of Mass General on Discovery of Novel Pancreatic Cancer Cell Subtype

212

Going Beyond Time Barriers: Arutha Kulasinghe on the Power of New Spatial Biology Tools

213

Invitae’s Data Manager, Farid Vij, on New Genome Management Platform

214

Satellite Bio out with a New Tissue Based Approach to Regenerative Medicine

215

We Have to Get Sequencing Back to Moore’s Law: Gilad Almogy, Ultima Genomics

216

RNA Therapeutics: A New Paradigm for Drug Development? Tim Mercer, BASE Lab, U of Queensland

217

The System is Working. We Need More Engagement, Says ClinVar Champion Heidi Rehm of Mass General in Her Update on the State of Genomic Medicine in 2022

218

The Promise of Exosomes Now Realized, Says Paul Billings, CEO, Biological Dynamics

219

Lee Cronin on Origin of Life, Genomics, Aliens and More

220

Eric Green on the Future of the NHGRI

221

5-Base Sequencing: Jonas Korlach and Tomi Pastinen

222

More Cancer Patients Die from Infections than Cancer, Says Alec Ford, CEO of Karius

223

Some of the Lowest Hanging Fruits in Precision Medicine: Michelle Whirl-Carrillo on Pharmacogenomics

224

John Nelson of GE Research Talks Vaccines on Demand, Enzymatic Synthesis, and the Era of Writing DNA

225

A New Generation Comfortable Doing a Thousand Things at a Time Is Reinventing Life Science Says Joe Beechem of NanoString

226

Enabling a New Age of Unbiased Proteomics Discovery: Omid Farokhzad, Seer Inc.

227

The Rise of MRD Testing and the Field of Fragmentomics with Sugganth Daniel, Invitae

228

The Invention of Enzymatic DNA Synthesis with Sylvain Gariel, DNA Script

229

Akoya Biosciences Launches New Integrated Spatial Platform: Our First Interview with CEO Brian McKelligon

230

Harlan Robins on How T-cell Focused COVID Vaccines Can Move Us Toward Endemicity

231

Twist Bioscience: A New Kind of DNA Synthesis Company

232

Going High Resolution with 10X Genomics: Michael Schnall-Levin

233

George Church and Ben Lamm on the Launch of Colossal Biosciences

234

We Might Be the Comeback Kids of the Universe: Chris Mason on His Plan for the Next 500 Years

235

Invitae and PacBio CEOs Share Details of Clinical Sequencing Partnership

236

Building on the Knowledge Base of Developer Community, LuminexPLORE Lab Offers Custom Insights: Jackie Surls, Director

237

DNA Script Takes DNA Synthesis Back to the Bench with Enzymatic Tech: Thomas Ybert, CEO

238

Tumor Evolution in Context with Christina Curtis

239

The History of mRNA Vaccines with Elie Dolgin

240

Hundreds of Thousands of Biological Molecules Undiscovered in Plant Chemical Space Says Founder of New Drug Discovery Company

241

Quantitative Pathology with David Rimm, Yale

242

The State of Comprehensive Genomic Profiling at One of America’s Largest Health Systems with Carlo Bifulco

243

Inside the World of Genome Engineering at Amyris with Kirsten Benjamin, VP of R&D

244

Clinical Genetics 2021 Highlights: Laura Hercher, Host of the Beagle Landed Podcast

245

A New Way to Phenotype Life: Chris Mason Talks Spatial Biology, His New Book

246

The Impact of Spatial Technology on Childhood Cancers with David Steffin, Texas Children's

247

Robert Green: Newborn Sequencing Is the Goal Here in the U.S.

248

The Studies Are In—Optical Mapping Can Replace Traditional Cytogenetics Tests

249

Amy Sturm of Geisinger on FH Testing and New Implementation Science

250

Out of the Reductionist Trap: Brad Gray of NanoString on Spatial Biology

251

Precision Oncology at the Community Level with Lee Schwartzberg

252

Daniel Kraft on the Digitome and COVID

253

Orchid Health Is 1st in the World to Offer Whole Genome Couple's Report

254

PacBio and Labcorp Team Up on a Global Pan-Pathogen Surveillance Network

255

Will High Sensitivity Proteomics Enable a New Paradigm in Precision Health? with Kevin Hrusovsky, Quanterix

256

A Liquid Biopsy Technology that Doesn't Degrade the Sample: Raj Krishnan of Biological Dynamics

257

The Future of Big Biology: Bionano at AGBT

258

Playing Catch Up--Viral Surveillance in the U.S. with Will Lee of Helix

259

The Coronavirus, A Year On with Carl Zimmer

260

Spatial Biology Enables The Cancer Immunome Project

261

The CRISPR Saga with Kevin Davies

262

PacBio’s Never Been Stronger: New CEO, Christian Henry, Shares His Vision

263

Keith Robison on the State of Sequencing: 2020 Edition

264

Halloween with Nathan and Laura: The Spooky and Creepy of Genomics

265

When and Why Whole Genome Sequencing Should Be Standard of Care: Stephen Kingsmore of Rady Children’s

266

Limited Genetic Diversity Affects Us All

267

Genomics England Making Significant Strides in System Built on Trust in NHS

268

September 2020 Review with Nathan and Laura: Vaccine Choice, Dwarfism, Research Volunteerism

269

Bob Nussbaum on the State of Genetic Testing: 2020 Edition

270

SynBioBeta 2020 with John Cumbers

271

Mapping Intracellular Context: Garry Nolan on Spatial Biology

272

August 2020 Review: Radical Shift on LDT Policy, First Pan-Cancer Liquid Biopsies, and New Alzheimer’s Test

273

Using CRISPR Genome Editing Tools, Willow Biosciences out with First Synthetic Cannabinoid

274

The Pros and Cons of Expanded Carrier Screening with Mary Norton, UCSF

275

Is This A Unique Time for Science? We Ask Sci-fi Writer Kim Stanley Robinson

276

May 2020 with Nathan and Laura: Vaccine News, Notre Dame Argument, COVID Genetic Targets

277

Matt Loose on "Read Until" or Adaptive Sequencing

278

The Current State of Coronavirus Vaccines with Jeff Stein, Cidara Therapeutics

279

April 2020 Review with Nathan and Laura: Ioannidis Scandal, Antibody Testing, Ethics Questions

280

Lab Director Speaks to the Challenges of COVID-19 Testing: Elaine Lyon, HudsonAlpha

281

FDA in the Time of Coronavirus: Understanding the New VALID Act with Turna Ray, GenomeWeb

282

March 2020 Review with Nathan & Laura: Corona Gets Personal, Where Are the Tests?, the VALID Act, Some non-Corona Science

283

90% Go Undiagnosed, Says Geisinger’s Amy Sturm of FH Patients

284

Lisa Alderson on Her Telegenetics Firm, Genome Medical, Also Speaks to the DTC Downturn

285

February 2020 Review with Nathan and Laura: Coronavirus, Medicare for All, and Live from AGBT

286

Pouria Sanae on the DTC Slowdown and His New Precision Health Testing Platform

287

January 2020 Review: Genetic Counselors vs ACMG, 23andMe Layoffs, Privacy

288

End-of-Decade Review, What's Next? with Nathan and Laura

289

Ewan Birney on Race, UK Genomics

290

November 2019 with Nathan and Laura: Happy Birthday CRISPR Babies, 23andMe for Embryo Selection, and Golden Rice, Almost

291

Learning from the Field's Mistakes, Ancestry.com Rolls out Physician Ordered Health Testing

292

The Gene Edited Babies Saga - A Year Later with Hank Greely

293

Improving Quantitative Evidence for Genetic Tests: Carlos Araya, Invitae

294

The Meteoric Rise of Twist Bioscience and the Wild Demand for DNA: Emily Leproust, CEO

295

October 2019 Review with Nathan and Laura: Prime Editing, Vertex Win, and ASHG

296

Should We Increase Panel Testing for All Breast Cancer Patients?

297

Genomics Going from a Passive to an Active Science: John Stuelpnagel on the “Write” Revolution

298

Why Isn’t Personalized Medicine Being Mentioned by the Presidential Contenders? Ed Abrahams on Drug Pricing, Genetic Testing, and the State of the Industry in 2019

299

Karen Miga on the Next Era of Genomics

300

September 2019 Review with Nathan and Laura: Same-Sex Genetics, Mosquitos, and Another DTC Scandal